Company Research Report: CognitiveCare Inc.
1. Company Overview
Name
CognitiveCare Inc.
Mission of the Company
CognitiveCare relentlessly navigates towards health equity as our company's north star in everything we do. We are committed to deploying scientific rigor to unveil and address disparities, employing cutting-edge methodologies to enhance outcomes.
Founding Information
- Founded: 2018
- Founders: Venkata Narasimham Peri (PV) and Dr. Suresh Attili
Key People
- Venkat N. Peri: Co-Founder and Global CEO
- Dr. Suresh Attili: Co-Founder and Chief Physician Scientist
- Sheena Gill, JD: President and CEO of Americas, Founding Team Member
- Jagannadha Ganti: General Manager, India
- Naresh Nelaturi, PhD: Chief Data Scientist
- Dr. Errol Norwitz: Chief Innovation and Impact Officer
- Manoj Teltumbade, PhD: Chief Scientific Officer and Founding Team Member
Headquarters
1313 N Milpitas Blvd, Suite 169, Milpitas, CA 95035, USA
Number of Employees
No information is available.
Revenue
No information is available.
Company Notoriety
CognitiveCare is known for pioneering, patented, published, and proven AI solutions in healthcare, focusing on maternal and infant health, pediatrics, infectious diseases, pathology, mental health, and substance use disorders.
2. Products
Overview
CognitiveCare offers a suite of AI-driven predictive analytics products designed to improve healthcare outcomes by leveraging clinical, medical, image, claims, and social determinants of health (SDoH) data.
Products Offered
1. Maternal Infant Health Insights and Cognitive intelligence (MIHIC) Score®
- Description: Patented algorithms for identifying critical and adverse outcomes during pregnancy stages.
- Key Features:
- Identifies propensity for outcomes such as postpartum hemorrhage, preterm birth, and unplanned C-sections.
- Provides hyper-personalized intervention insights at population and individual levels.
2. Pathology Suite
- Description: Algorithms enhancing diagnostic accuracy for conditions affecting multiple organs.
- Key Features:
- Comprehensive health views for heart, kidney, liver, lungs, orthopedic conditions, and diabetes.
- Empowers patients with knowledge for effective prevention and chronic condition management.
3. Myopia and Retinopathy of Prematurity (RoP)
- Description: Predictive models for eye disease risks and progression.
- Key Features:
- Identifies early signs and helps in timely intervention to prevent blindness in infants and manage myopia in children.
4. Sepsis Prediction Models
- Description: Deep learning-based models to predict sepsis outcomes.
- Key Features:
- Competing risk survival models for hospital settings.
- Supports early treatment to reduce sepsis fatalities.
3. Recent Developments
Recent Developments in the Company
1. Healthcare Accelerator and Funding
- AWS Healthcare Accelerator: Selected for the 2022 AWS Healthcare Accelerator focused on improving health equity.
- Bill & Melinda Gates Foundation Grant: Received nearly $1 million to advance maternal and fetal health.
New Products and Features
No information is available on specific new products or newly added features.
New Partnerships
Partnership with LV Prasad Eye Institute (LVPEI):
- Objective: Enhance early detection of eye diseases in infants and children.
- Details: Collaborative effort to leverage CognitiveCare’s AI models and LVPEI's clinical expertise.
Additional Introductions
No information is available on further recent introductions.
This report compiles the available data on CognitiveCare Inc., focusing on the company's mission, key people, product offerings, and recent activities. For more in-depth information, it is recommended to contact the company directly.
